Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 21,516 shares at $32.14 ($691K) on 2026-01-12, disclosed to the SEC on 2026-01-13.
Open-market sale of $691k MLYS by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.14 | 10,758 | $346K | 50.0% |
| 2 | $32.14 | 10,758 | $346K | 50.0% |
| Total | $32.14 avg | 21,516 | $691K | 100% |
| Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |
| MLYS | SELL | 2025-04-15 | $259K | — | Filing → |